Liposomal delivery of radionuclides for cancer diagnostics and radiotherapy: From material development to in vivo applications using positron emission tomography (PET) imaging

Medicine and Dentistry

• Positron Emission Tomography 100%
• Radiation Therapy 100%
• Radioisotope 100%
• Development 100%
• Liposome 100%
• Cancer Diagnostics 100%
• Obstetric Delivery 100%
• Copper 64 50%
• Neoplasm 50%
• Chelating Agent 25%
• Polyethylene Glycol 25%
• Diagnostic Imaging 20%
• Lutetium 177 20%
• Neuroendocrine Tumor 20%
• Radioactive Tracer 15%
• Ionophore 15%
• Single-Photon Emission Computed Tomography 15%
• Somatostatin Derivative 15%
• Measurement 10%
• Biodistribution 10%
• Ligand 10%
• Somatostatin Receptor 10%
• Imaging Agent 10%
• Indium 111 10%
• Malignant Neoplasm 10%
• Evaluation Study 10%
• Drug 10%
• Chemotherapeutic Agent 10%
• Patient 10%
• Tumor Cell 5%
• Receptor 5%
• Pharmacokinetics 5%
• Macrogol 5%
• Circulation 5%
• Tetraxetan 5%
• Positron Emission Tomography-Computed Tomography 5%
• Clearance 5%
• Scintigraphy 5%
• Molecular Imaging 5%
• Radiation Exposure 5%
• Quinolinol Derivative 5%
• Isothermal Titration Calorimetry 5%
• Cancer Radiotherapy 5%
• Radiopharmaceutical Agent 5%
• Life 5%
• Enalapril Maleate 5%
• Aptitude 5%
• Diagnostics 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Radioisotope 100%
• Liposome 100%
• Malignant Neoplasm 100%
• Neoplasm 60%
• Copper 64 50%
• Chelating Agent 25%
• Lutetium 177 20%
• Neuroendocrine Tumor 20%
• Mouse 20%
• Enhanced Permeability and Retention Effect 20%
• Tracer 15%
• Ionophore 15%
• Somatostatin Derivative 15%
• Ligand 10%
• Biodistribution 10%
• Indium 111 10%
• Computed Tomography Studies 10%
• Macrogol 5%
• Pharmacokinetics 5%
• Receptor 5%
• Tetraxetan 5%
• Macrogol Derivative 5%
• Drug 5%
• Radiopharmaceutical Agent 5%
• Quinolinol Derivative 5%
• Enalapril Maleate 5%
• Animal 5%
• Drug Development 5%
• Calorimetry 5%
• Radiation Exposure 5%